Quantitative Equity Solutions Client Portfolio Manager Associate
About the job
- A quantitative orientation and strong financial, statistical, and investment knowledge and interest.
- A strong interest in financial markets and investment management, paired with a strong desire to engage with clients.
- Strong PowerPoint and Excel skills.
- One to four years of relevant work experience.
- Develop subject matter expertise in QES investment strategies and the portfolio management approach.
- Serve as a product expert on QES investment strategies for internal and external clients of the Division and the Firm, and provide support to senior team members.
- Communicate with sales personnel, financial advisors, and clients to understand client goals and provide education on investment solutions.
- Create client-specific proposals and analysis tailored to individual investors’ needs.
- Collaborate with teams across the division to drive the commercial success of the business.
- Support advisors, salespeople, and clients in understanding account lifecycle events and prepare account performance commentary.
- Build working relationships across the business and work with portfolio managers, strategists, and engineers to gain insight into the investment process.
- Work with compliance, legal, controllers, operations, and other groups to improve clients’ investment experience.
- Collaborate with the investment team, sales, and marketing to create marketing collateral and determine appropriate delivery formats, such as webinars, blog posts, and white papers.
- Independently develop solutions, materials, research, and projects for internal and external clients.
- Update marketing materials quarterly.
- Experience and background with quantitative techniques and investment strategies.
- A computer programming background or experience, including experience with C, C++, Java, Python, R, or MATLAB.
About the company
Goldman Sachs provides financial services for corporations, governments, institutions, and individuals, including advisory on mergers and acquisitions, underwriting and distributing securities, asset and wealth management, and market making across fixed income, currencies, commodities, and equities. Its products work by delivering strategic advice, financing, liquidity, and asset management across multiple classes, using client funds and its own capital to raise, deploy, and manage capital for clients. The firm differentiates itself through its global scale, comprehensive range of services, deep client relationships, and long-standing presence in capital markets. Its goal is to help clients raise and deploy capital, manage risk, and grow wealth while earning fees and returns from advisory, trading, lending, and asset management activities.
Company Size
10,001+
Company Stage
IPO
Headquarters
New York City, New York
Founded
1869
Get referred to Goldman Sachs
See people who can refer or advise you
Simplify's Take
What believers are saying
- Second-quarter 2026 revenue rose 39.5% to $20.34 billion, crushing estimates.
- Goldman added NEOS Investments in August 2026, boosting active ETF scale.
- The Fed's 2026 softer capital rules and higher dividend support buybacks and returns.
What critics are saying
- Malaysia filed 2026 criminal charges over 1MDB against Goldman units and Jho Low.
- The $500 million 1MDB shareholder settlement extends reputational damage through 2026.
- Succession uncertainty around David Solomon and John Waldron threatens leadership stability into 2027.
What makes Goldman Sachs unique
- Goldman Sachs dominated 2026 M&A fees, reinforcing elite adviser status.
- Its record $4.04 trillion assets under supervision deepen cross-sell across banking and wealth.
- David Solomon's OneGS 3.0 links trading, onboarding, and compliance into firmwide operating leverage.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Paid Vacation
Paid Sick Leave
Paid Holidays
Professional Development Budget
Company News
With its first debt financing round, one of America’s fastest-growing corporate cards can serve more customers
The first corporate card that helps businesses spend less experiences record-setting adoption as it nears $1B in annualized transaction volume just one year after the product’s general availability.
GoodLeap has closed a $389 million securitisation, its 26th overall and sixth backed solely by home improvement loans. The transaction, GoodLeap Home Improvement Solutions Trust 2026-2, was sponsored by Bank of America and is backed by $434 million in principal balance of GoodLeap-originated loans. The securitisation received ratings from Kroll Bond Rating Agency and Fitch Ratings. Joint bookrunners included Goldman Sachs, CIBC World Markets, and Citigroup Global Markets. GoodLeap provides financing and software for sustainable home solutions including solar panels, batteries, and energy-efficient HVAC systems. Since 2018, the company has facilitated more than $38 billion in financing, serving over 1.7 million homeowners. The sustainable home upgrades market represents an estimated $450 billion annual opportunity in the United States.
Goldman Sachs has committed up to an additional £500m to Quantum Development Finance, potentially expanding the specialist lender's funding capacity to £700m. The expanded long-term facility represents potential funding capacity rather than capital already advanced to borrowers. Quantum provides development and bridging finance to SME housebuilders and property investors across England and Wales, offering loans typically between £1m and £30m. The lender has financed approximately 4,000 homes since its 2023 founding and passed £1bn in cumulative funding during the summer. The commitment contrasts with pressure elsewhere in development finance, where firms face challenges from build-cost inflation and subdued markets. Quantum also partners with alternative investment manager AB CarVal for long-term funding.
89bio, a San Francisco-based clinical-stage biopharmaceutical company, has raised approximately $287.5 million through a public offering of common stock and pre-funded warrants. Gibson Dunn advised on the transaction. The company focuses on developing therapies for patients with liver and cardiometabolic diseases lacking optimal treatment options. Goldman Sachs, Leerink Partners, and BofA Securities served as lead book-running managers for the offering, with Cantor acting as book-running manager. The Gibson Dunn team included Ryan Murr, Branden Berns, Melanie Neary, Lauren Navarro, and Jasmine Vitug.